{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T08:43:09Z","timestamp":1794040989488,"version":"4.8.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T00:00:00Z","timestamp":1600992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T00:00:00Z","timestamp":1600992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UK Medical Research Council","doi-asserted-by":"crossref","award":["LSHTM PhD Studentship Doctoral Training Programme"],"award-info":[{"award-number":["LSHTM PhD Studentship Doctoral Training Programme"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>As malaria transmission declines, sensitive diagnostics are needed to evaluate interventions and monitor transmission. Serological assays measuring malaria antibody responses offer a cost-effective detection method to supplement existing surveillance tools.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A prospective cohort study was conducted from 2013 to 2015 in 12 villages across five administrative regions in The Gambia. Serological analysis included samples from the West Coast Region at the start and end of the season (July and December 2013) and from the Upper River Region in July and December 2013 and April and December 2014. Antigen-specific antibody responses to eight\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      (\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      ) antigens\u2014Etramp5.Ag1, GEXP18, HSP40.Ag1, Rh2.2030, EBA175 RIII-V,\n                      <jats:italic>Pf<\/jats:italic>\n                      MSP1\n                      <jats:sub>19<\/jats:sub>\n                      ,\n                      <jats:italic>Pf<\/jats:italic>\n                      AMA1, and\n                      <jats:italic>Pf<\/jats:italic>\n                      GLURP.R2\u2014were quantified using a multiplexed bead-based assay. The association between antibody responses and clinical and parasitological endpoints was estimated at the individual, household, and population level.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Strong associations were observed between clinical malaria and concurrent sero-positivity to Etramp5.Ag1 (aOR 4.60 95% CI 2.98\u20137.12),\n                      <jats:italic>Pf<\/jats:italic>\n                      MSP1\n                      <jats:sub>19<\/jats:sub>\n                      (aOR 4.09 95% CI 2.60\u20136.44),\n                      <jats:italic>Pf<\/jats:italic>\n                      AMA1 (aOR 2.32 95% CI 1.40\u20133.85), and\n                      <jats:italic>Pf<\/jats:italic>\n                      GLURP.R2 (aOR 3.12, 95% CI 2.92\u20134.95), while asymptomatic infection was associated with sero-positivity to all antigens. Village-level sero-prevalence amongst children 2\u201310\u2009years against Etramp5.Ag1, HSP40.Ag1, and\n                      <jats:italic>Pf<\/jats:italic>\n                      MSP1\n                      <jats:sub>19<\/jats:sub>\n                      showed the highest correlations with clinical and\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      infection incidence rates. For all antigens, there were increased odds of asymptomatic\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      infection in subjects residing in a compound with greater than 50% sero-prevalence, with a 2- to 3-fold increase in odds of infection associated with Etramp5.Ag1, GEXP18, Rh2.2030,\n                      <jats:italic>Pf<\/jats:italic>\n                      MSP1\n                      <jats:sub>19<\/jats:sub>\n                      , and\n                      <jats:italic>Pf<\/jats:italic>\n                      AMA1. For individuals residing in sero-positive compounds, the odds of clinical malaria were reduced, suggesting a protective effect.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>At low transmission, long-lived antibody responses could indicate foci of malaria transmission that have been ongoing for several seasons or years. In settings where sub-patent infections are prevalent and fluctuate below the detection limit of polymerase chain reaction (PCR), the presence of short-lived antibodies may indicate recent infectivity, particularly in the dry season when clinical cases are rare. Serological responses may reflect a persistent reservoir of infection, warranting community-targeted interventions if individuals are not clinically apparent but have the potential to transmit. Therefore, serological surveillance at the individual and household level may be used to target interventions where there are foci of asymptomatically infected individuals, such as by measuring the magnitude of age-stratified antibody levels or identifying areas with clustering of above-average antibody responses across a diverse range of serological markers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-020-01724-5","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T21:02:56Z","timestamp":1600981376000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Antibody responses to a suite of novel serological markers for malaria surveillance demonstrate strong correlation with clinical and parasitological infection across seasons and transmission settings in The Gambia"],"prefix":"10.1186","volume":"18","author":[{"given":"Lindsey","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Mwesigwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muna","family":"Affara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamadou","family":"Bah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susheel K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Beeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin K. A.","family":"Tetteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immo","family":"Kleinschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"D\u2019Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Drakeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,25]]},"reference":[{"key":"1724_CR1","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/ncomms2241","volume":"3","author":"LC Okell","year":"2012","unstructured":"Okell LC, Bousema T, Griffin JT, Ou\u00e9draogo AL, Ghani AC, Drakeley CJ. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun. 2012;3:1237 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23212366. [cited 2016 Apr 5].","journal-title":"Nat Commun"},{"issue":"12","key":"1724_CR2","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nrmicro3364","volume":"12","author":"T Bousema","year":"2014","unstructured":"Bousema T, Okell L, Felger I, Drakeley C. Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat Rev Microbiol. 2014;12(12):833\u201340 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25329408. [cited 2016 Apr 5].","journal-title":"Nat Rev Microbiol"},{"issue":"7580","key":"1724_CR3","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1038\/nature16039","volume":"528","author":"L Wu","year":"2015","unstructured":"Wu L, van den Hoogen LL, Slater H, Walker PGT, Ghani AC, Drakeley CJ, et al. Comparison of diagnostics for the detection of asymptomatic Plasmodium falciparum infections to inform control and elimination strategies. Nature. 2015;528(7580):S86\u201393 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26633770. [cited 2016 Apr 5].","journal-title":"Nature"},{"issue":"1","key":"1724_CR4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4269\/ajtmh.2005.73.191","volume":"73","author":"L Andrews","year":"2005","unstructured":"Andrews L, Andersen RF, Webster D, Dunachie S, Walther RM, Bejon P, et al. Quantitative real-time polymerase chain reaction for malaria diagnosis and its use in malaria vaccine clinical trials. Am J Trop Med Hyg. 2005;73(1):191\u20138 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16014857. [cited 2017 Nov 21].","journal-title":"Am J Trop Med Hyg"},{"key":"1724_CR5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1475-2875-10-48","volume":"10","author":"RJ Rockett","year":"2011","unstructured":"Rockett RJ, Tozer SJ, Peatey C, Bialasiewicz S, Whiley DM, Nissen MD, et al. A real-time, quantitative PCR method using hydrolysis probes for the monitoring of Plasmodium falciparum load in experimentally infected human volunteers. Malar J. 2011;10:48.","journal-title":"Malar J"},{"key":"1724_CR6","doi-asserted-by":"crossref","unstructured":"Okebe J, Affara M, Correa S, Muhammad AK, Nwakanma D, Drakeley C, et al. School-based countrywide seroprevalence survey reveals spatial heterogeneity in malaria transmission in the Gambia. Fernandez-Reyes D, editor. PLoS One 2014;9(10):e110926. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25338083. [cited 2018 May 12].","DOI":"10.1371\/journal.pone.0110926"},{"issue":"1","key":"1724_CR7","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/s12936-015-0939-1","volume":"14","author":"LL van den Hoogen","year":"2015","unstructured":"van den Hoogen LL, Griffin JT, Cook J, Sep\u00falveda N, Corran P, Conway DJ, et al. Serology describes a profile of declining malaria transmission in Farafenni, The Gambia. Malar J. 2015;14(1):416 Available from: http:\/\/www.malariajournal.com\/content\/14\/1\/416. [cited 2018 Jun 13].","journal-title":"Malar J"},{"issue":"14","key":"1724_CR8","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1073\/pnas.0408725102","volume":"102","author":"CJ Drakeley","year":"2005","unstructured":"Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SLR, Carneiro I, et al. Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci U S A. 2005;102(14):5108\u201313 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15792998. [cited 2017 Oct 30].","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"1724_CR9","doi-asserted-by":"crossref","first-page":"e25137","DOI":"10.1371\/journal.pone.0025137","volume":"6","author":"J Cook","year":"2011","unstructured":"Cook J, Kleinschmidt I, Schwabe C, Nseng G, Bousema T, Corran PH, et al. Serological markers suggest heterogeneity of effectiveness of malaria control interventions on Bioko Island, equatorial Guinea. PLoS One. 2011;6(9):e25137 Available from: http:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0025137. [cited 2015 Jun 16].","journal-title":"PLoS One"},{"issue":"1","key":"1724_CR10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12936-017-1701-7","volume":"16","author":"J Biggs","year":"2017","unstructured":"Biggs J, Raman J, Cook J, Hlongwana K, Drakeley C, Morris N, et al. Serology reveals heterogeneity of Plasmodium falciparum transmission in northeastern South Africa: implications for malaria elimination. Malar J. 2017;16(1):48 Available from: http:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-017-1701-7. [cited 2018 Aug 15].","journal-title":"Malar J"},{"issue":"32","key":"1724_CR11","doi-asserted-by":"crossref","first-page":"E4438","DOI":"10.1073\/pnas.1501705112","volume":"112","author":"DA Helb","year":"2015","unstructured":"Helb DA, Tetteh KKA, Felgner PL, Skinner J, Hubbard A, Arinaitwe E, et al. Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities. Proc Natl Acad Sci U S A. 2015;112(32):E4438\u201347 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26216993. [cited 2017 Oct 30].","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1724_CR12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1186\/s12936-016-1576-z","volume":"15","author":"K Kerkhof","year":"2016","unstructured":"Kerkhof K, Sluydts V, Willen L, Kim S, Canier L, Heng S, et al. Serological markers to measure recent changes in malaria at population level in Cambodia. Malar J. 2016;15(1):529 Available from: http:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-016-1576-z. [cited 2017 Nov 1].","journal-title":"Malar J"},{"issue":"11","key":"1724_CR13","doi-asserted-by":"crossref","first-page":"e0187059","DOI":"10.1371\/journal.pone.0187059","volume":"12","author":"J Mwesigwa","year":"2017","unstructured":"Mwesigwa J, Achan J, Di Tanna GL, Affara M, Jawara M, Worwui A, et al. Residual malaria transmission dynamics varies across The Gambia despite high coverage of control interventions. Carvalho LH, editor. PLoS One. 2017;12(11):e0187059 Available from: http:\/\/dx.plos.org\/10.1371\/journal.pone.0187059. [cited 2018 Feb 5].","journal-title":"PLoS One"},{"issue":"1","key":"1724_CR14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0166-6851(94)90144-9","volume":"64","author":"PA Burghaus","year":"1994","unstructured":"Burghaus PA, Holder AA. Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein. Mol Biochem Parasitol. 1994;64(1):165\u20139 Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/0166685194901449?via%3Dihub. [cited 2018 Apr 26].","journal-title":"Mol Biochem Parasitol"},{"issue":"10","key":"1724_CR15","doi-asserted-by":"crossref","first-page":"7431","DOI":"10.1074\/jbc.M610562200","volume":"282","author":"CR Collins","year":"2007","unstructured":"Collins CR, Withers-Martinez C, Bentley GA, Batchelor AH, Thomas AW, Blackman MJ. Fine mapping of an epitope recognized by an invasion-inhibitory monoclonal antibody on the malaria vaccine candidate apical membrane antigen 1. J Biol Chem. 2007;282(10):7431\u201341 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17192270. [cited 2018 Apr 26].","journal-title":"J Biol Chem"},{"key":"1724_CR16","doi-asserted-by":"crossref","unstructured":"Theisen M, Vuust J, Gottschau A, Jepsen S, H\u00f8gh B. Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli. 1995;2(1):30\u20134. Available from: http:\/\/cvi.asm.org\/content\/2\/1\/30.full.pdf. [cited 2018 Apr 26].","DOI":"10.1128\/cdli.2.1.30-34.1995"},{"issue":"8","key":"1724_CR17","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1086\/656413","volume":"51","author":"JS Richards","year":"2010","unstructured":"Richards JS, Stanisic DI, Fowkes FJI, Tavul L, Dabod E, Thompson JK, et al. Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia. Clin Infect Dis. 2010;51(8):e50\u201360 Available from: https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1086\/656413. [cited 2018 Apr 26].","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1724_CR18","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1128\/IAI.69.2.1084-1092.2001","volume":"69","author":"T Triglia","year":"2001","unstructured":"Triglia T, Thompson J, Caruana SR, Delorenzi M, Speed T, Cowman AF. Identification of proteins from Plasmodium falciparum that are homologous to reticulocyte binding proteins in Plasmodium vivax. Infect Immun. 2001;69(2):1084\u201392 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11160005. [cited 2018 Apr 26].","journal-title":"Infect Immun"},{"issue":"4","key":"1724_CR19","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1091\/mbc.e02-04-0240","volume":"14","author":"T Spielmann","year":"2003","unstructured":"Spielmann T, Fergusen DJP, Beck H-P. etramps, a new Plasmodium falciparum gene family coding for developmentally regulated and highly charged membrane proteins located at the parasite-host cell interface. Mol Biol Cell. 2003;14(4):1529\u201344 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12686607. [cited 2018 Apr 26].","journal-title":"Mol Biol Cell"},{"issue":"6","key":"1724_CR20","doi-asserted-by":"crossref","first-page":"e0006457","DOI":"10.1371\/journal.pntd.0006457","volume":"12","author":"LS Herman","year":"2018","unstructured":"Herman LS, Fornace K, Phelan J, Grigg MJ, Anstey NM, William T, et al. Identification and validation of a novel panel of Plasmodium knowlesi biomarkers of serological exposure. Barry AE, editor. PLoS Negl Trop Dis. 2018;12(6):e0006457 Available from: https:\/\/dx.plos.org\/10.1371\/journal.pntd.0006457. [cited 2020 Apr 1].","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"1724_CR21","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1128\/IAI.00301-13","volume":"81","author":"KKA Tetteh","year":"2013","unstructured":"Tetteh KKA, Osier FHA, Salanti A, Kamuyu G, Drought L, Failly M, et al. Analysis of antibodies to newly described plasmodium falciparum merozoite antigens supports MSPDBL2 as a predicted target of naturally acquired immunity. Infect Immun. 2013;81(10):3835\u201342.","journal-title":"Infect Immun"},{"issue":"4","key":"1724_CR22","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1128\/IAI.71.4.1833-1842.2003","volume":"71","author":"SD Polley","year":"2003","unstructured":"Polley SD, Tetteh KKA, Cavanagh DR, Pearce RJ, Lloyd JM, Bojang KA, et al. Repeat sequences in block 2 of Plasmodium falciparum merozoite surface protein 1 are targets of antibodies associated with protection from malaria. Infect Immun. 2003;71(4):1833\u201342.","journal-title":"Infect Immun"},{"key":"1724_CR23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.12688\/wellcomeopenres.14950.1","volume":"4","author":"L Wu","year":"2019","unstructured":"Wu L, Hall T, Ssewanyana I, Oulton T, Patterson C, Vasileva H, et al. Optimisation and standardisation of a multiplex immunoassay of diverse Plasmodium falciparum antigens to assess changes in malaria transmission using sero-epidemiology. Wellcome Open Res. 2019;4:26 Available from: https:\/\/wellcomeopenresearch.org\/articles\/4-26\/v1. [cited 2019 Mar 5].","journal-title":"Wellcome Open Res"},{"key":"1724_CR24","first-page":"103","volume":"72","author":"G Snounou","year":"2002","unstructured":"Snounou G. Genotyping of Plasmodium spp. Nested PCR Methods Mol Med. 2002;72:103\u201316.","journal-title":"Nested PCR Methods Mol Med"},{"issue":"6","key":"1724_CR25","doi-asserted-by":"crossref","first-page":"e6083","DOI":"10.1371\/journal.pone.0006083","volume":"4","author":"L Stewart","year":"2009","unstructured":"Stewart L, Gosling R, Griffin J, Gesase S, Campo J, Hashim R, et al. Rapid assessment of malaria transmission using age-specific sero-conversion rates. PLoS One. 2009;4(6):e6083 Available from: http:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0006083. [cited 2015 Jun 19].","journal-title":"PLoS One"},{"key":"1724_CR26","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.4269\/ajtmh.18-0303","volume":"99","author":"B Greenhouse","year":"2018","unstructured":"Greenhouse B, Smith DL, Rodr\u00edguez-Barraquer I, Mueller I, Drakeley CJ. Taking sharper pictures of Malaria with CAMERAs: Combined antibodies to measure exposure recency assays. Am J Trop Med Hygiene. 2018;99:1120\u20137 Available from: \/pmc\/articles\/PMC6221205\/?report=abstract. [cited 2020 Jul 20].","journal-title":"Am J Trop Med Hygiene"},{"issue":"37","key":"1724_CR27","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1016\/j.vaccine.2013.06.042","volume":"31","author":"LM Murungi","year":"2013","unstructured":"Murungi LM, Kamuyu G, Lowe B, Bejon P, Theisen M, Kinyanjui SM, et al. A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria. Vaccine. 2013;31(37):3936\u201342 Available from: \/pmc\/articles\/PMC3763364\/?report=abstract. [cited 2020 Jun 24].","journal-title":"Vaccine"},{"issue":"2","key":"1724_CR28","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1128\/IAI.02398-14","volume":"83","author":"DI Stanisic","year":"2015","unstructured":"Stanisic DI, Fowkes FJI, Koinari M, Javati S, Lin E, Kiniboro B, et al. Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response. Infect Immun. 2015;83(2):646\u201360 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25422270. [cited 2018 Apr 30].","journal-title":"Infect Immun"},{"issue":"1","key":"1724_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-08528-z","volume":"10","author":"L Reiling","year":"2019","unstructured":"Reiling L, Boyle MJ, White MT, Wilson DW, Feng G, Weaver R, et al. Targets of complement-fixing antibodies in protective immunity against malaria in children. Nat Commun. 2019;10(1):1\u201313 Available from: https:\/\/www.nature.com\/articles\/s41467-019-08528-z. [cited 2020 Jun 24].","journal-title":"Nat Commun"},{"issue":"14","key":"1724_CR30","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1073\/pnas.0408725102","volume":"102","author":"CJ Drakeley","year":"2005","unstructured":"Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SLR, Carneiro I, et al. Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci U S A. 2005;102(14):5108\u201313 Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=555970&tool=pmcentrez&rendertype=abstract. [cited 2015 Jun 5].","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7828","key":"1724_CR31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(73)92361-1","volume":"2","author":"LJ Bruce-Chwatt","year":"1973","unstructured":"Bruce-Chwatt LJ, Draper CC, Konfortion P. Seroepidemiological evidence of eradication of malaria from Mauritius. Lancet (London). 1973;2(7828):547\u201351 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/4125305. [cited 2015 Jul 13].","journal-title":"Lancet (London)"},{"issue":"1","key":"1724_CR32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1186\/1475-2875-13-451","volume":"13","author":"J Wong","year":"2014","unstructured":"Wong J, Hamel MJ, Drakeley CJ, Kariuki S, Shi YP, Lal AA, et al. Serological markers for monitoring historical changes in malaria transmission intensity in a highly endemic region of Western Kenya, 1994\u20132009. Malar J. 2014;13(1):451 Available from: http:\/\/www.malariajournal.com\/content\/13\/1\/451. [cited 2015 May 29].","journal-title":"Malar J"},{"issue":"1","key":"1724_CR33","doi-asserted-by":"crossref","first-page":"19472","DOI":"10.1038\/srep19472","volume":"6","author":"V Yman","year":"2016","unstructured":"Yman V, White MT, Rono J, Arc\u00e0 B, Osier FH, Troye-Blomberg M, et al. Antibody acquisition models: a new tool for serological surveillance of malaria transmission intensity. Sci Rep. 2016;6(1):19472 Available from: http:\/\/www.nature.com\/articles\/srep19472. [cited 2017 Nov 1].","journal-title":"Sci Rep"},{"issue":"32","key":"1724_CR34","doi-asserted-by":"crossref","first-page":"E4438","DOI":"10.1073\/pnas.1501705112","volume":"112","author":"DA Helb","year":"2015","unstructured":"Helb DA, Tetteh KKA, Felgner PL, Skinner J, Hubbard A, Arinaitwe E, et al. Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities. Proc Natl Acad Sci U S A. 2015;112(32):E4438\u201347 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26216993. [cited 2015 Jul 31].","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"1724_CR35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-1759(01)00500-2","volume":"259","author":"A Irion","year":"2002","unstructured":"Irion A, Beck HP, Smith T. Assessment of positivity in immuno-assays with variability in background measurements: a new approach applied to the antibody response to Plasmodium falciparum MSP2. J Immunol Methods. 2002;259(1\u20132):111\u20138 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11730846. [cited 2018 may 31].","journal-title":"J Immunol Methods"},{"key":"1724_CR36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/1475-2875-12-221","volume":"12","author":"JF Mosha","year":"2013","unstructured":"Mosha JF, Sturrock HJW, Greenhouse B, Greenwood B, Sutherland CJ, Gadalla N, et al. Epidemiology of subpatent Plasmodium falciparum infection: implications for detection of hotspots with imperfect diagnostics. Malar J. 2013;12:221 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23815811. [cited 2016 Apr 5].","journal-title":"Malar J"},{"key":"1724_CR37","doi-asserted-by":"crossref","unstructured":"Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014;5 Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4202688\/. [cited 2018 Jun 10].","DOI":"10.3389\/fimmu.2014.00520"},{"key":"1724_CR38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molimm.2015.03.255","volume":"67","author":"V Irani","year":"2015","unstructured":"Irani V, Guy AJ, Andrew D, Beeson JG, Ramsland PA, Richards JS. Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases. Mol Immunol. 2015;67:171\u201382 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25900877\/. [cited 2020 Jun 27].","journal-title":"Mol Immunol"},{"issue":"8","key":"1724_CR39","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1086\/656413","volume":"51","author":"JS Richards","year":"2010","unstructured":"Richards JS, Stanisic DI, Fowkes FJI, Tavul L, Dabod E, Thompson JK, et al. Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia. Clin Infect Dis. 2010;51(8):e50\u201360 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/20843207\/. [cited 2020 Jun 27].","journal-title":"Clin Infect Dis"},{"key":"1724_CR40","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1128\/IAI.01129-08","volume":"77","author":"DI Stanisie","year":"2009","unstructured":"Stanisie DI, Richards JS, McCallum FJ, Michon P, King CL, Schoepflin S, et al. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness. Infect Immun. 2009;77:1165\u201374 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19139189\/. [cited 2020 Jun 27].","journal-title":"Infect Immun"},{"issue":"6","key":"1724_CR41","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1086\/655660","volume":"202","author":"GI Perez-Perez","year":"2010","unstructured":"Perez-Perez GI, Maw AM, Feingold-Link L, Gunn J, Bowers AL, Minano C, et al. Longitudinal analysis of serological responses of adults to Helicobacter pylori antigens. J Infect Dis. 2010;202(6):916\u201323 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/20698790\/. [cited 2020 Jun 27].","journal-title":"J Infect Dis"},{"issue":"5","key":"1724_CR42","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.exger.2013.02.011","volume":"48","author":"B Simon","year":"2013","unstructured":"Simon B, Kundi M, Puchhammer-St\u00f6ckl E. Association of HCMV specific IgG subclass antibody levels with gender and age. Exp Gerontol. 2013;48(5):472\u20135 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23422355\/. [cited 2020 Jun 27].","journal-title":"Exp Gerontol"},{"issue":"2","key":"1724_CR43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1128\/CVI.05523-11","volume":"19","author":"C Doba\u00f1o","year":"2012","unstructured":"Doba\u00f1o C, Quelhas D, Quint\u00f3 L, Puyol L, Serra-Casas E, Mayor A, et al. Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children. Clin Vaccine Immunol. 2012;19(2):157\u201366 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22169088. [cited 2018 may 28].","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"1724_CR44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1128\/IAI.74.1.257-264.2006","volume":"74","author":"JE Tongren","year":"2006","unstructured":"Tongren JE, Drakeley CJ, McDonald SLR, Reyburn HG, Manjurano A, Nkya WMM, et al. Target antigen, age, and duration of antigen exposure independently regulate immunoglobulin G subclass switching in malaria. Infect Immun. 2006;74(1):257\u201364 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16368979. cited 2018 Apr 30].","journal-title":"Infect Immun"},{"issue":"9","key":"1724_CR45","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-3024.2009.01138.x","volume":"31","author":"SL Takala","year":"2009","unstructured":"Takala SL, Plowe CV. Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming \u2018vaccine resistant malaria.\u2019. Parasite Immunol. 2009;31(9):560\u201373 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19691559. [cited 2018 Jun 7].","journal-title":"Parasite Immunol"},{"issue":"1","key":"1724_CR46","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev.micro.61.080706.093134","volume":"62","author":"A Scherf","year":"2008","unstructured":"Scherf A, Lopez-Rubio JJ, Riviere L. Antigenic variation in Plasmodium falciparum. Annu Rev Microbiol. 2008;62(1):445\u201370 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18785843. [cited 2018 Jun 7].","journal-title":"Annu Rev Microbiol"},{"issue":"21","key":"1724_CR47","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa1505819","volume":"373","author":"DE Neafsey","year":"2015","unstructured":"Neafsey DE, Juraska M, Bedford T, Benkeser D, Valim C, Griggs A, et al. Genetic diversity and protective efficacy of the RTS,S\/AS01 malaria vaccine. N Engl J Med. 2015;373(21):2025\u201337 Available from: http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa1505819. [cited 2018 Apr 30].","journal-title":"N Engl J Med"},{"issue":"1","key":"1724_CR48","doi-asserted-by":"crossref","first-page":"20613","DOI":"10.1038\/srep20613","volume":"6","author":"B Krishnarjuna","year":"2016","unstructured":"Krishnarjuna B, Andrew D, MacRaild CA, Morales RAV, Beeson JG, Anders RF, et al. Strain-transcending immune response generated by chimeras of the malaria vaccine candidate merozoite surface protein 2. Sci Rep. 2016;6(1):20613 Available from: http:\/\/www.nature.com\/articles\/srep20613. [cited 2018 Jun 18].","journal-title":"Sci Rep"},{"key":"1724_CR49","doi-asserted-by":"crossref","first-page":"131","DOI":"10.12688\/gatesopenres.12897.1","volume":"3","author":"B Greenhouse","year":"2019","unstructured":"Greenhouse B, Daily J, Guinovart C, Goncalves B, Beeson J, Bell D, et al. Priority use cases for antibody-detecting assays of recent malaria exposure as tools to achieve and sustain malaria elimination. Gates Open Res. 2019;3:131 Available from: https:\/\/gatesopenresearch.org\/articles\/3-131\/v1. [cited 2019 Mar 5].","journal-title":"Gates Open Res"},{"key":"1724_CR50","doi-asserted-by":"crossref","unstructured":"Hsiang MS, Ntshalintshali N, Kang Dufour M-S, Dlamini N, Nhlabathi N, Vilakati S, et al. Active case finding for malaria: a 3-year national evaluation of optimal approaches to detect infections and hotspots through reactive case detection in the low-transmission setting of Eswatini. Clin Infect Dis. 2019; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31095677. [cited 2020 Feb 19].","DOI":"10.1093\/cid\/ciz403"},{"key":"1724_CR51","first-page":"6","volume":"5","author":"V Yman","year":"2016","unstructured":"Yman V, White MT, Rono J, Arc\u00e0 B, Osier FH, Troye-Blomberg M, et al. Antibody acquisition models: a new tool for serological surveillance of malaria transmission intensity. Sci Rep. 2016;5:6.","journal-title":"Sci Rep"},{"issue":"1","key":"1724_CR52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12916-019-1482-7","volume":"18","author":"H Surendra","year":"2020","unstructured":"Surendra H, Supargiyono ARA, Kusumasari RA, Rahayujati TB, Damayanti SY, et al. Using health facility-based serological surveillance to predict receptive areas at risk of malaria outbreaks in elimination areas. BMC Med. 2020;18(1):9 Available from: https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-019-1482-7. [cited 2020 Jul 20].","journal-title":"BMC Med"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-01724-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-020-01724-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-01724-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T19:34:50Z","timestamp":1632512090000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-020-01724-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,25]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1724"],"URL":"https:\/\/doi.org\/10.1186\/s12916-020-01724-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.07.10.20067488","asserted-by":"object"}]},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,25]]},"assertion":[{"value":"15 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by The Gambia Government\/MRC Joint Ethics Committee (SCC1318). Verbal consent was first obtained at village sensitisation meetings, followed by individual written informed consent for all participants. Parents\/guardians provided written consent for children less than 17\u2009years, and assent was obtained from children between 12 and 17\u2009years.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"304"}}